Sten Verland
InvestorMember of the InnoFounder selection committee at Innovation Fund Denmark · Venture Partner at Sunstone Capital
Denmark
Find your path to Sten
98 people in our graph share verified history with Sten — schools, employers, funds. One of them is your warm intro.
Gordon RausserunlockedSten: together at Department of Genetics, UC Berkeley, USA (1986)
Sten: together at Innovation Fund Denmark
×2Sten: together at DVCA - Danish Venture Capital and Private Equity Association
Sten: together at BioInnovation Institute
About
Sten Verland is a venture partner and founding partner at Sunstone Life Science Ventures who brings experience in executive management, venture capital, and pharmaceutical development. He holds a PhD in Immunology and has served as a CEO, board member, and chairman across biotech and pharmaceutical companies, with expertise in drug development, M&A, and fundraising. Verland also participates in innovation funding committees supporting early-stage life science ventures.
Contact· self-published, not guessed
Experience
- Sunstone Life Science VenturesVenture Partner (founding partner)current2024 — presentCopenhagen Metropolitan Area
- Sunstone Life Science VenturesGeneral Partner (founding partner)2007 — 2024Copenhagen Metropolitan Area
- Verland - Life Science Venture & ConsultingCEO & Ownercurrent1994 — presentCopenhagen Metropolitan Area
- Minervax ApSNon Executive Directorcurrent2014 — presentCopenhagen Metropolitan Area
- Minervax ApSChair of the Audit Committeecurrent2020 — presentCopenhagen Metropolitan Area
- Sulis TherapeuticsChair of the Board of Directorscurrent2026 — presentAarhus, Central Denmark Region, Denmark
- Proxi BiotechChair of the Board of Directorscurrent2025 — presentCoopenhagen, Denmark
- Innovation Fund DenmarkMember of the InnoFounder selection committeecurrent2014 — presentCopenhagen Metropolitan Area
- Innovation Fund DenmarkMember of the InnoExplorer selection committee2019 — 2024Copenhagen Metropolitan Area
- Innovation Fund DenmarkMember of the InnoBooster selection committee2018 — 2021Copenhagen Metropolitan Area
- Skovlyst Production A/SNon Executive Directorcurrent2018 — presentCopenhagen Metropolitan Area
- Skovlyst Production A/SPrivate investor (through Verland Capital ApS)current2009 — presentCoopenhagen, Denmark
- The Research Council of NorwayPanel Member2020 — 2025Oslo, Norway
- Neumirna TherapeuticsChair of the Board of Directors2022 — 2025Copenhagen Metropolitan Area
- Anergis SANon Executive Director2011 — 2024Lausanne, Vaud, Switzerland
- Stipe TherapeuticsMember of the Audit Committee2019 — 2024Aarhus, Central Denmark Region, Denmark
- Stipe TherapeuticsNon Executive Director2019 — 2024Aarhus, Central Denmark Region, Denmark
- Vaximm AGBoard Observer2019 — 2022Basel, Switzerland
- Vaximm AGNon Executive Director2011 — 2019Basel, Switzerland
- OxTheraNon Executive Director2016 — 2022Greater Stockholm Metropolitan Area
- Orphazyme A/SMember of the Audit Committee2017 — 2021Copenhagen Metropolitan Area
- Orphazyme A/SMember of the Nomination Committee2017 — 2021Copenhagen Metropolitan Area
- Orphazyme A/SNon Executive Director2011 — 2021Copenhagen Metropolitan Area
- BioInnovation InstituteMember of the selection committee for the Creation House incubator2018 — 2020Copenhagen Metropolitan Area
- DVCA - Danish Venture Capital and Private Equity AssociationMember of the Board of Directors2012 — 2020Copenhagen Metropolitan Area
- DVCA - Danish Venture Capital and Private Equity AssociationMember of the Venture Capital Committee2012 — 2020Copenhagen Metropolitan Area
- Glycom A/SPrivate investor (through Verland Capital)2005 — 2020Copenhagen Metropolitan Area
- Glycom A/SNon Executive Director2005 — 2007Copenhagen Metropolitan Area
- F2G LTDNon Executive Director2010 — 2018Greater Manchester, England, United Kingdom
- Rigontec GmbHNon Executive Director2015 — 2017Cologne Bonn Region
- NsGene A/SNon Executive Director2014 — 2017Copenhagen Metropolitan Area
- ZymenexChair of the Board of Directors2010 — 2013Hillerød, Denmark
- ZymenexNon Executive Director2006 — 2010Hillerød, Denmark
- Action Pharma A/SChair of the Board of Directors2009 — 2012Aarhus, Central Denmark Region, Denmark
- Synarc (now Clario)VP General Manager Europe1999 — 2003Copenhagen Metropolitan Area & San Francisco Bay Area
- M&B A/S (now Taconic Biosciences)CEO & co-owner1993 — 1999Copenhagen Metropolitan Area
- Scanpharm A/SHead of R&D1990 — 1992Copenhagen Metropolitan Area
- Institute for Experimental Immunology, Medical School, University of CopenhagenAssistant Professor1989
- Department of Clinical Chemistry, Bispebjerg Hospital, CopenhagenSenior Research Scientist1988 — 1989
- Institute for Experimental Immunology, Medical School, University of CopenhagenResearch Scientist1986 — 1987
Skills & more
Venture Capital59Biotechnology45Entrepreneurship37Drug Development19Lifesciences19Mergers9Business Strategy12Immunology12Corporate Development9Mergers & Acquisitions8R&D6Clinical Development5
+12 more
StrategyExecutive ManagementPrivate EquityPharmaceutical IndustryAngel InvestingVenture FinancingClinical TrialsIPONegotiationAdvisory BoardsStart-upsCommercializationLanguages Danish · English · German · Other Scandinavian languages
From Sten's professional profile.
Colleagues at Innovation Fund Denmark
Andrew Bartholomew
Founder and Managing Partner at Fulcrum Venture
Erik Steffensen
Expert advisor at VÅR Ventures
Gina Domanig
Managing Partner, CEO at Emerald Technology Ventures Ag
Lene Gerlach
Venture Partner at Hadean Ventures
Louise Lachmann
Partner at Ugly Duckling Ventures
Mia Grosen
Venture Partner at SuperSeed
Niels V. Carlsen
GP at Final Frontier (Space & Defence VC)
Peidong Xu
Analyst at Everplus Capital
Frequently asked questions
- Who is Sten Verland?
- Sten Verland is a venture partner and founding partner at Sunstone Life Science Ventures who brings experience in executive management, venture capital, and pharmaceutical development. He holds a PhD in Immunology and has served as a CEO, board member, and chairman across biotech and pharmaceutical companies, with expertise in drug development, M&A, and fundraising. Verland also participates in innovation funding committees supporting early-stage life science ventures.
- Where does Sten Verland work?
- Sten Verland is Member of the InnoFounder selection committee at Innovation Fund Denmark.
- Where did Sten Verland go to school?
- Sten Verland studied at Københavns Universitet - University of Copenhagen (Doctor of Philosophy - PhD, Immunology); Københavns Universitet - University of Copenhagen (Master of Science - MSc, Biology and Mathematics).
Founder mafias
Københavns Universitet - University of Copenhagen mafia66
Also came through, then founded or led a company.
David HelgasonPhysicsFounded Unity SoftwareUlrik B. NielsenDoctor of Philosophy (PhD)Founded Tidal Therapeutics +1Gerry Giacomán ColyerEuropean Politics & SocietyFounded Clara +1Emil MunkData ScienceFounded Balance +1Christian LanngMasterFounded Beyond Work Holdings +1Mikkel PrechtKandidatgradFounded Ada Ventures +1
+ 59 more
Innovation Fund Denmark mafia4
Also came through, then founded or led a company.
MinervaX mafia2
Also came through, then founded or led a company.
Same school
Also attended Københavns Universitet - University of Copenhagen213
David HelgasonUnity co-founder; Partner at TransitionJesper GromadaInvestor at Third Rock VenturesUlrik B. NielsenGeneral Partner at Mission BiocapitalTommy AhlersFormer Danish Science Minister at Giant Ventures Global LlpTaro HizumeGeneral Partner at Ff Venture CapitalClaus AnderssonGeneral Partner at Sunstone Capital
+ 207 more
